1/26
Comprehensive vocabulary flashcards detailing renal diagnostics, laboratory thresholds, acute and chronic kidney disease, pyelonephritis, glomerulonephritis, and dialysis modalities for NCLEX-NGN review.
Serum Creatinine
The end product of muscle metabolism and the most sensitive indicator of kidney function, unaffected by diet, with a normal reference range of 0.6–1.2mg/dL in males and 0.4–1.0mg/dL in females.
Blood Urea Nitrogen (BUN)
The end product of protein breakdown with a normal reference range of 8–20mg/dL, which is altered by protein intake, dehydration, fever, and gastrointestinal bleeding.
BUN-to-Creatinine Ratio
A diagnostic indicator with a normal baseline of ∼10:1 to 20:1; an elevated ratio (>20:1) indicates a prerenal state (hypoperfusion or dehydration), whereas parallel increases indicate intrarenal damage.
Creatinine Clearance
The best clinical estimate of glomerular filtration rate (GFR) with a normal range of 85–135mL/min, requiring a 24-hour urine collection where the first void is discarded and the sample is kept on ice.
Isosthenuria
A clinical state characterized by a fixed urine specific gravity at 1.010, reflecting the total loss of renal concentrating ability in End-Stage Kidney Disease.
Renal Biopsy
The gold standard diagnostic procedure used to confirm a specific histological renal diagnosis, after which the client must lie flat for 2–6hours and be closely monitored for bleeding and gross hematuria.
Pyelonephritis
A bacterial infection of the renal pelvis and kidney parenchyma (upper UTI) typically caused by ascending Escherichia coli, characterized by fever, chills, leukocytosis, bacteriuria, pyuria, and costovertebral angle (CVA) / flank pain.
Glomerulonephritis
Inflammation of glomerular capillaries caused by immune complex (IgG) deposition, classically following Group A Beta-Hemolytic Streptococcus infection, resulting in cola-colored urine, proteinuria, decreased GFR, azotemia, periorbital edema, and hypertension.
Vasa Recta Mechanism
A pathophysiologic process in glomerulonephritis where impaired blood flow through the vasa recta prevents renal monitoring of blood pressure, triggering inappropriate renin release and severe secondary hypertension.
KDIGO AKI Criteria
Diagnostic criteria defining Acute Kidney Injury by an increase in serum creatinine of ≥0.3mg/dL within 48hours, an increase ≥1.5× baseline within 7days, or urine output <0.5mL/kg/hr for >6hours.
Prerenal AKI
A category of acute kidney injury driven by hypoperfusion (e.g., hypovolemia, shock, hemorrhage, burns, heart failure) characterized by a BUN:Cr ratio >20:1, urine sodium <20mEq/L, and urine specific gravity >1.020.
Intrarenal AKI
A category of acute kidney injury resulting from parenchymal damage (e.g., acute tubular necrosis, nephrotoxic drugs, contrast dye, rhabdomyolysis) presenting with a BUN:Cr ratio of ∼10–15:1, urine sodium >40mEq/L, and urinary casts/debris.
Postrenal AKI
A category of acute kidney injury caused by mechanical outflow obstruction (e.g., renal calculi, BPH, prostate cancer, strictures), characterized by sudden anuria or variable oliguria.
Initiation Phase (AKI)
The asymptomatic first phase of acute kidney injury beginning with the initial precipitating insult and subsequent cellular damage.
Oliguric Phase (AKI)
The second phase of acute kidney injury defined by urine output <400mL/24 hr, marked by retention of urea, creatinine, phosphorus, potassium, and magnesium, with high risks of hyperkalemia and fluid overload.
Diuretic Phase (AKI)
The third phase of acute kidney injury marked by daily urine outputs of 1–5L/day as nephrons recover without intact concentrating ability, placing the client at high risk for hypokalemia, hyponatremia, and hypovolemia.
Recovery Phase (AKI)
The final stage of acute kidney injury occurring over 3 to 12months, during which GFR stabilizes and overall renal function approaches baseline.
Chronic Kidney Disease (CKD)
Kidney damage or an estimated GFR (eGFR) <60mL/min/1.73m2 persisting for >3months, primarily caused by diabetes mellitus and hypertension.
Calcium Gluconate
An intravenous agent administered during severe hyperkalemic emergencies to protect and stabilize cardiac myocardial membranes against lethal dysrhythmias.
Sevelamer (Renagel)
A non-absorbed phosphate binder that must be taken with meals and snacks to bind dietary phosphorus within the gastrointestinal tract and prevent systemic absorption.
Epoetin alfa (Epogen/Procrit)
A synthetic erythropoietin administered subcutaneously to stimulate red blood cell production for anemia of CKD, with a target hemoglobin level of <12g/dL (10–11g/dL) to prevent hypertension and thrombosis.
Arteriovenous (AV) Fistula
A long-term hemodialysis vascular access created by the surgical anastomosis of an artery directly to a vein, requiring approximately 3months to mature.
Thrill and Bruit
The dual clinical markers of patency in a dialysis AV fistula or graft, consisting of a palpable vibration (thrill) and an audible swishing murmur on auscultation (bruit).
Peritonitis
The primary infectious complication of peritoneal dialysis, clinically signaled by cloudy or turbid dialysate effluent drainage, abdominal pain, and fever.
Continuous Veno-Venous Hemofiltration (CVVH)
A continuous kidney replacement therapy (CKRT) modality used in the ICU that provides slow, continuous fluid and solute removal over 24hours for hemodynamically unstable clients.
Dialysis Disequilibrium Syndrome
A severe central nervous system complication of hemodialysis caused by rapid removal of blood urea creating an osmotic gradient that shifts fluid into cerebral cells, presenting with headache, nausea, restlessness, and confusion.
Uremic Frost
A dermatologic sign of advanced uremia where urea crystals deposit directly onto the skin surface, typically accompanied by severe pruritus and a metallic taste in the mouth.